loadpatents
name:-0.016871929168701
name:-0.011059999465942
name:-0.0106201171875
Wilson; Bryan R. Patent Filings

Wilson; Bryan R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilson; Bryan R..The latest application filed is for "microcrystalline diketopiperazine compositions and methods".

Company Profile
11.24.27
  • Wilson; Bryan R. - Brewster NY
  • Wilson; Bryan R. - Bedford NY
  • Wilson; Bryan R. - Granite Springs NY
  • Wilson; Bryan R. - Tuxedo NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Microcrystalline Diketopiperazine Compositions and Methods
App 20220048868 - Wilson; Bryan R. ;   et al.
2022-02-17
Microcrystalline diketopiperazine compositions and methods
Grant 11,192,862 - Wilson , et al. December 7, 2
2021-12-07
Oral Formulations of Kappa Opioid Receptor Agonists
App 20210346505 - WILSON; Bryan R. ;   et al.
2021-11-11
Oligosaccharide Formulations Of Kappa Opioid Receptor Agonists
App 20210290723 - WILSON; Bryan R. ;   et al.
2021-09-23
Oral formulations of kappa opioid receptor agonists
Grant 11,033,629 - Wilson , et al. June 15, 2
2021-06-15
Diketopiperazine salts for drug delivery and related methods
App 20210138041 - Leone-Bay; Andrea ;   et al.
2021-05-13
Diketopiperazine salts for drug delivery and related methods
Grant 10,912,821 - Leone-Bay , et al. February 9, 2
2021-02-09
Microcrystalline Diketopiperazine Compositions and Methods
App 20200339520 - Wilson; Bryan R. ;   et al.
2020-10-29
Microcrystalline diketopiperazine compositions and methods
Grant 10,745,359 - Wilson , et al. A
2020-08-18
Diketopiperazine Salts For Drug Delivery And Related Methods
App 20200164044 - Leone-Bay; Andrea ;   et al.
2020-05-28
Oral Formulations of Kappa Opioid Receptor Agonists
App 20200085961 - WILSON; Bryan R. ;   et al.
2020-03-19
Diketopiperazine salts for drug delivery and related methods
Grant 10,583,176 - Leone-Bay , et al.
2020-03-10
Microcrystalline Diketopiperazine Compositions And Methods
App 20190359576 - Wilson; Bryan R. ;   et al.
2019-11-28
Method For Improving The Pharmaceutic Properties Of Microparticles Comprising Diketopiperazine And An Active Agent
App 20190314276 - Wilson; Bryan R. ;   et al.
2019-10-17
Microcrystalline diketopiperazine compositions and methods
Grant 10,421,729 - Wilson , et al. Sept
2019-09-24
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
Grant 10,376,466 - Wilson , et al. A
2019-08-13
Diketopiperazine Salts For Drug Delivery And Related Methods
App 20190030133 - Leone-Bay; Andrea ;   et al.
2019-01-31
Method For Improving The Pharmaceutic Properties Of Microparticles Comprising Diketopiperazine And An Active Agent
App 20190029954 - Wilson; Bryan R. ;   et al.
2019-01-31
Diketopiperazine salts for drug delivery and related methods
Grant 10,130,685 - Leone-Bay , et al. November 20, 2
2018-11-20
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
Grant 10,130,581 - Wilson , et al. November 20, 2
2018-11-20
Diketopiperazine salts for drug delivery and related methods
App 20170274050 - Leone-Bay; Andrea ;   et al.
2017-09-28
Diketopiperazine salts for drug delivery and related methods
Grant 9,675,674 - Leone-Bay , et al. June 13, 2
2017-06-13
Diketopiperazine salts for drug delivery and related methods
App 20160250297 - Leone-Bay; Andrea ;   et al.
2016-09-01
Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
Grant 9,399,065 - Pohl , et al. July 26, 2
2016-07-26
Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
Grant 9,381,247 - Pohl , et al. July 5, 2
2016-07-05
Method For Improving The Pharmaceutic Properties Of Microparticles Comprising Diketopiperazine And An Active Agent
App 20160101049 - Wilson; Bryan R. ;   et al.
2016-04-14
Diketopiperazine salts for drug delivery and related methods
Grant 9,259,471 - Leone-Bay , et al. February 16, 2
2016-02-16
Microcrystalline Diketopiperazine Compositions And Methods
App 20160031833 - Wilson; Bryan R. ;   et al.
2016-02-04
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
Grant 9,241,903 - Wilson , et al. January 26, 2
2016-01-26
Stabilized Ultra-rapid-acting Insulin Formulations
App 20150273022 - Wilson; Bryan R. ;   et al.
2015-10-01
Magnesium Compositions for Modulating the Pharmacokinetics and Injection Site Pain of Insulin
App 20140357554 - Pohl; Roderike ;   et al.
2014-12-04
Diketopiperazine salts for drug delivery and related methods
App 20140227359 - Leone-Bay; Andrea ;   et al.
2014-08-14
Magnesium Compositions for Modulating the Pharmacokinetics and Pharmacodynamics of Insulin and Insulin Analogs, and Injection Site Pain
App 20140113856 - Pohl; Roderike ;   et al.
2014-04-24
Diketopiperazine salts for drug delivery and related methods
Grant 8,653,085 - Leone-Bay , et al. February 18, 2
2014-02-18
Method For Improving The Pharmaceutic Properties Of Microparticles Comprising Diketopiperazine And An Active Agent
App 20130303445 - Wilson; Bryan R. ;   et al.
2013-11-14
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
Grant 8,512,932 - Wilson , et al. August 20, 2
2013-08-20
Diketopiperazine Salts For Drug Delivery And Related Methods
App 20120328676 - Leone-Bay; Andrea ;   et al.
2012-12-27
Diketopiperazine salts for drug delivery and related methods
Grant 8,278,308 - Leone-Bay , et al. October 2, 2
2012-10-02
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
App 20120010133 - Wilson; Bryan R. ;   et al.
2012-01-12
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
Grant 8,039,431 - Wilson , et al. October 18, 2
2011-10-18
Diketopiperazine Salts for Drug Delivery and Related Methods
App 20110008448 - Leone-Bay; Andrea ;   et al.
2011-01-13
Dry powder formulations of antihistamine for nasal administration
Grant 7,833,549 - Steiner , et al. November 16, 2
2010-11-16
Dry powder formulations of antihistamine for nasal administration
Grant 7,833,550 - Steiner , et al. November 16, 2
2010-11-16
Diketopiperazine salts for drug delivery and related methods
Grant 7,820,676 - Leone-Bay , et al. October 26, 2
2010-10-26
Dry Powder Formulations Of Antihistamine For Nasal Administration
App 20080038358 - Steiner; Solomon S. ;   et al.
2008-02-14
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
App 20070196503 - Wilson; Bryan R. ;   et al.
2007-08-23
Diketopiperazine salts for drug delivery and related methods
App 20060040953 - Leone-Bay; Andrea ;   et al.
2006-02-23
Dry powder formulations of antihistamine for nasal administration
App 20020009418 - Steiner, Solomon S. ;   et al.
2002-01-24
M.sub.2 receptor ligand for the treatment of neurological disorders
Grant 5,712,269 - McCabe , et al. January 27, 1
1998-01-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed